Clarus Therapeutics Reports First Quarter 2022 Financial and Operating Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/4/2026

1. KRG
2. SPY
3. ALAR
4. SKA-B
5. PBA
6. CCH:LN
7. META
8. CCHGY
9. PRY:IM
10. PRYMY

Go back to Clarus Therapeutics Reports First Quarter 2022 Financial and Operating Results

Clarus Therapeutics (CRXT) Misses Q1 EPS by 21c

May 16, 2022 4:12 PM EDT

Clarus Therapeutics (NASDAQ: CRXT) reported Q1 EPS of ($0.61), $0.21 worse than the analyst estimate of ($0.40). Revenue for the quarter came in at $4 million versus the consensus estimate of $5.5 million.

For earnings history and earnings-related data on Clarus Therapeutics (CRXT) click here.

... More